T2DM has in meta-analyses been associated with lower levels of the bone turnover markers; osteocalcin, CrossLaps, and procollagen type 1 amino terminal propeptide [18, 34] indicating a lower bone turnover. This evidence concerns the gene BGLAP and type 2 diabetes mellitus.